会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Short bio-active peptides for cellular and immunological modulation
    • 用于细胞和免疫调节的短生物活性肽
    • US07696174B2
    • 2010-04-13
    • US12005653
    • 2007-12-27
    • Scott M. HarrisLijuan ZhangTimothy J. Falla
    • Scott M. HarrisLijuan ZhangTimothy J. Falla
    • A61K38/08A61K31/74
    • C07K14/43563A61K38/00C07K5/1024C07K7/08
    • Peptides having four to fourteen residues are disclosed that possess biological activity. These peptides constitute short fragments of the peptide HB-107 (SEQ ID NO:1), which itself is a fragment of the antimicrobial protein cecropin B, and exhibit cell stimulatory, migratory and anti-inflammatory properties. As keratinocytes are especially sensitive to these effects, the disclosed peptides comprise a useful agent for the medical treatment of injury to the skin, such as from diabetic ulcers. The peptides also are effective in preventing and reversing skin surface damage resulting from various environmental insults. Importantly, the therapeutic effects of the peptides manifest at concentrations equal to or greater than those of peptide HB-107, and thus represent a less expensive, more versatile means for developing effective therapies. Methods for the production and use of these peptides are also disclosed.
    • 披露具有四至十四个残基的肽具有生物活性。 这些肽构成肽HB-107(SEQ ID NO:1)的短片段,其本身是抗微生物蛋白质天蚕素B的片段,并且具有细胞刺激性,迁移性和抗炎性质。 由于角质形成细胞对这些作用特别敏感,所公开的肽包括用于治疗皮肤损伤(例如糖尿病性溃疡)的有用试剂。 这些肽也有效地预防和逆转由各种环境污染引起的皮肤表面损伤。 重要的是,肽的治疗效果以等于或大于肽HB-107的浓度表现,因此代表开发有效疗法的较便宜,更通用的手段。 还公开了生产和使用这些肽的方法。
    • 3. 发明授权
    • Protective skin care peptides
    • 保护性皮肤护理肽
    • US08071555B2
    • 2011-12-06
    • US12290236
    • 2008-10-28
    • Lijuan ZhangScott M. HarrisTimothy J. Falla
    • Lijuan ZhangScott M. HarrisTimothy J. Falla
    • A61K38/06A61K9/00
    • C07K5/1024A61K8/64A61K38/00A61K2800/782A61Q19/08
    • The disclosed invention provides tetrapeptides with the amino acid sequence proline-glutamine-glutamate-X (P-Q-E-X), where X can be either lysine (K) or isoleucine (I). These tetrapeptides inhibit ultraviolet light (UV)-induced expression of the pro-inflammatory cytokine interleukin-6 (IL-6) by skin epithelial cells and fibroblasts. Furthermore, the tetrapeptides repress the upregulation of matrix metalloproteinase-1 (MMP-1) by skin fibroblasts induced by either direct exposure to UV rays or treatment with media conditioned by UV-treated keratinocytes. The small size and bio-activity of the tetrapeptides render them suitable for use in therapies directed to inflammatory skin disorders and as active ingredients in skin care products.
    • 所公开的发明提供四肽与氨基酸序列脯氨酸 - 谷氨酰胺 - 谷氨酸酯-X(P-Q-E-X),其中X可以是赖氨酸(K)或异亮氨酸(I)。 这些四肽通过皮肤上皮细胞和成纤维细胞抑制紫外线(UV)诱导的促炎细胞因子白细胞介素-6(IL-6)的表达。 此外,四肽通过直接暴露于紫外线诱导的皮肤成纤维细胞抑制基质金属蛋白酶-1(MMP-1)的上调或通过经紫外线处理的角质形成细胞调节的培养基来治疗。 四肽的小尺寸和生物活性使其适合用于治疗炎症性皮肤病症和作为皮肤护理产品中的活性成分。
    • 4. 发明授权
    • Antimicrobial hexapeptides
    • 抗菌六肽
    • US07407940B2
    • 2008-08-05
    • US11350192
    • 2006-02-08
    • Timothy J. FallaLijuan ZhangScott M. Harris
    • Timothy J. FallaLijuan ZhangScott M. Harris
    • A61K38/08C07K7/06
    • C07K7/06A61K38/00Y02A50/473
    • The invention encompasses hexapeptides consisting of alternating hydrophobic residues (B) at positions 2, 4, and 6, hydrophilic, charged residues (X) at positions 1 and 3, and a naphthylalanine (Nal), an aliphatic or aromatic residue (O) at position five, represented generally by the formula XBXBOB, which exhibit antimicrobial activity against infections caused by a variety of pathogens. These pathogens may include gram positive or negative bacteria, acid-fast bacteria such as mycobacteria, parasites, dermatophytes, or fungal pathogens. Typical fungal pathogens include Candida albicans and typical dermatophytes include Trichophyton rubrum and Trichophyton mentagrophytes. The hexapeptides of the present invention exhibit antifungal activity, antibacterial activity, desirable stability, and lack toxicity to the mammal receiving treatment.
    • 本发明包括由位置2,4和6处的交替的疏水性残基(B),位置1和3的亲水性带电残基(X)和萘丙氨酸(Nal),脂族或芳族残基(O))组成的六肽 位置5,通常由式XBXBOB表示,其表现出针对由各种病原体引起的感染的抗微生物活性。 这些病原体可以包括革兰氏阳性或阴性细菌,耐酸细菌如分枝杆菌,寄生虫,皮肤真菌或真菌病原体。 典型的真菌病原体包括白色念珠菌和典型的皮肤癣菌包括红色毛癣菌和引发毛癣菌。 本发明的六肽对接受治疗的哺乳动物具有抗真菌活性,抗菌活性,理想的稳定性和缺乏毒性。
    • 7. 发明申请
    • Short bio-active peptides for cellular and immunological modulation
    • 用于细胞和免疫调节的短生物活性肽
    • US20080206160A1
    • 2008-08-28
    • US12005653
    • 2007-12-27
    • Scott M. HarrisLijuan ZhangTimothy J. Falla
    • Scott M. HarrisLijuan ZhangTimothy J. Falla
    • A61K9/12C07K2/00C07K7/06A61K38/02A61K38/08A61P17/02A61K38/10
    • C07K14/43563A61K38/00C07K5/1024C07K7/08
    • Peptides having four to fourteen residues are disclosed that possess biological activity. These peptides constitute short fragments of the peptide HB-107 (SEQ ID NO:1), which itself is a fragment of the antimicrobial protein cecropin B, and exhibit cell stimulatory, migratory and anti-inflammatory properties. As keratinocytes are especially sensitive to these effects, the disclosed peptides comprise a useful agent for the medical treatment of injury to the skin, such as from diabetic ulcers. The peptides also are effective in preventing and reversing skin surface damage resulting from various environmental insults. Importantly, the therapeutic effects of the peptides manifest at concentrations equal to or greater than those of peptide HB-107, and thus represent a less expensive, more versatile means for developing effective therapies. Methods for the production and use of these peptides are also disclosed.
    • 披露具有四至十四个残基的肽具有生物活性。 这些肽构成肽HB-107(SEQ ID NO:1)的短片段,其本身是抗微生物蛋白质天蚕素B的片段,并且具有细胞刺激性,迁移性和抗炎性质。 由于角质形成细胞对这些作用特别敏感,所公开的肽包括用于治疗皮肤损伤(例如糖尿病性溃疡)的有用试剂。 这些肽也有效地预防和逆转由各种环境污染引起的皮肤表面损伤。 重要的是,肽的治疗效果以等于或大于肽HB-107的浓度表现,因此代表开发有效疗法的较便宜,更通用的手段。 还公开了生产和使用这些肽的方法。